Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model

Zika virus (ZIKV) infection is associated with serious, long-term neurological manifestations. There are currently no approved therapies for the treatment or prevention of ZIKV infection. Favipiravir (FAV) is a viral polymerase inhibitor with broad-spectrum activity. Our prior studies used static FA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Pires de Mello, Camilly P., Tao, Xun, Kim, Tae Hwan, Vicchiarelli, Michael, Bulitta, Jürgen B., Kaushik, Ajeet, Brown, Ashley N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2018
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125552/
https://ncbi.nlm.nih.gov/pubmed/29967017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00967-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados